The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate.

MLA

Aceituno, Laia, et al. “The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate.” Frontiers in Medicine, vol. 9, July 2022, p. 916213. EBSCOhost, https://doi.org/10.3389/fmed.2022.916213.

APA

Aceituno, L., Bañares, J., Ruiz-Ortega, L., Callejo-Pérez, A., Muñoz-Couselo, E., Ortiz-Velez, C., Díaz-Mejía, N., Barreira-Díaz, A., Carreras, M. J., Farriols, A., Buti, M., & Riveiro-Barciela, M. (2022). The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate. Frontiers in Medicine, 9, 916213. https://doi.org/10.3389/fmed.2022.916213

Chicago

Aceituno, Laia, Juan Bañares, Lourdes Ruiz-Ortega, Ana Callejo-Pérez, Eva Muñoz-Couselo, Carolina Ortiz-Velez, Nely Díaz-Mejía, et al. 2022. “The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate.” Frontiers in Medicine 9 (July): 916213. doi:10.3389/fmed.2022.916213.